COVID-19 is a considerable threat to health and not only during its active stage. Even after recovery, patients can be affected by COVID-19-related complications. Overwhelming production of inflammatory cytokines may lead to immune system dysregulation and lung structure alteration. It can also cause pathologic fibrotic processes reducing vital capacity of the lungs even after elimination of SARS-CoV-2. Immune system dysregulation may lead to exacerbation of chronic and autoimmune disorders such as diabetes mellitus, rheumatoid arthritis, neuroinflammatory conditions etc. In order to decrease the risk of COVID-19-related complications caused by compromised immune system and extensive lung damage, scientists and doctors of Infinity Clinic developed integrated treatment program based on the unique properties of fetal stem cells and fetal tissue extracts.
Powerful therapeutic approach for improvement and maintenance of lung health
Our research group was among the first laboratories in the world that discovered outstanding immunomodulatory properties of fetal stem cells. These results were published by our scientists in the Journal of Transplantology in 2004. Stem cells have a remarkable ability to differentiate into different cell types capable of replacing damaged and dying cells. Additionally, these cells produce a variety of anti-inflammatory cytokines and trophic factors suppressing immune system overactivation that, if uncontrolled, can become self-damaging (mechanism of autoimmune processes). Properly selected fetal stem cells facilitate macrophages activity pattern change - from damaging to healing, which results in regeneration of body tissues.
Our unique experience in chronic lung disorders demonstrated that stem cell treatment can be regarded as a powerful therapeutic approach for improvement and maintenance of lung health. Our patients with chronic pulmonary fibrosis showed significant improvement in blood oxygenation and overall life quality.
Оverall recovery during the post-COVID-19 period
Unlike the vast majority of stem cell clinics, we have a unique opportunity to use and apply different tissue-specific stem cells and corresponding fetal tissue extracts to match specific health needs of our patients.
Collaboration of our research and medical team resulted in comprehensive treatment program combining different types of stem cell products for immunomodulation, reduced risk of pulmonary fibrosis and overall recovery during the post-COVID-19 period.
For optimal results, stem cell treatment will be preceded by thorough full-body check-up and extensive testing in order to select additional medical procedures for support of the main therapy and its effects enhancement and maintenance.
This comprehensive immunomodulation program is a 5-day treatment during which patients stay in the modern luxury medical center located in a quiet and picturesque suburb of Kyiv.
Comprehensive Lung Health Program includes:
- Consultation and examination of the Head Doctor and General Practitioner
Laboratory tests:
- CBC (complete blood count)
- Blood chemistry
- Urine test
- Immunologic blood test
- Coagulation test
- Other tests (if necessary)
Instrumental examinations:
- Ultrasound of the abdomen and pelvis
- ECG and other studies depending on the results of the examination
- Chest CT scan
Stem Cell therapy:
- Placenta extract (subcutaneously)
- Hematopoietic stem cells (intravenous)
- Neural stem cells (subcutaneously)
- Thymus stem cells (subcutaneously)
- Lung stem cells (subcutaneously)
- Medicinal treatment
- Body detox
- Plasmapheresis
We introduce 1.5 million stem cells per kg of body weight of a patient
Cell viability or survival rate is over 90%
Quantity and type of stem cells and extracts is a subject to change depending on test and examination results, detected co-morbidity etc.